Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-04-05
2011-04-05
Landsman, Robert (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C436S086000
Reexamination Certificate
active
07919260
ABSTRACT:
Disclosed are compounds or their salts that promote or inhibit the activities of a protein comprising the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, compounds or their salts that promote or inhibit the activities of a gene for the protein, antisense polynucleotides comprising the whole or part of a base sequence complimentary or substantially complimentary to the base sequence of a polynucleotide encoding the protein or its partial peptide, antibodies to the protein, etc. These compounds or their salts, antisense nucleotides, antibodies, etc. can be used as agents for the prevention/treatment of mental disorders, prolactin-related disorders, etc.
REFERENCES:
patent: 7241579 (2007-07-01), Andrews et al.
patent: 7303889 (2007-12-01), Le Poul et al.
patent: 7354726 (2008-04-01), Hinuma et al.
patent: 1 477 806 (2004-11-01), None
patent: WO-2004/040000 (2004-05-01), None
patent: WO-2005/095990 (2005-10-01), None
M. Sawzdargo, et al., “Identification and cloning of three novel human G protein-coupled receptor genes GPR52, GPR53 and GPR55: GPR55 is extensively expressed in human brain” Molecular Brain Research, vol. 64, 1999, pp. 193-198.
D. Koike, et al., “Analysis of G protein-coupled receptors: Ligand searches through high-throughput screening”, Igaku-no-Ayumi, vol. 212, No. 1, 2005, pp. 29-34, English Abstract.
F. Nara, “G-protein coupled receptor (GPCR)- Targeted recent drug discovery”, Igaku-no-Ayumi, vol. 212, No. 1, 2005, pp. 35-40, English Abstract.
C. Melchiorre, et al., “Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine”, European Journal of Pharmacology, vol. 144, 1987, pp. 117-124.
V. Petkov, et al., “Plants with Hypotensive, Antiatheromatous and Coronarodilatating Action”, American Journal of Chinese Medicine, vol. VII, No. 3, pp. 197-236.
Supplementary European Search Report for corresponding EP 06 72 9848.
Itoh Yasuaki
Komatsu Hidetoshi
Maruyama Minoru
Mori Masaaki
Conlin David G.
Edwards Angell Palmer & & Dodge LLP
Landsman Robert
Swiszcz Lisa
Takeda Pharmaceutical Company Limited
LandOfFree
Screening methods using GPR52 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening methods using GPR52, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening methods using GPR52 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2670309